Cerebral Blood Perfusion Predicts Response to Sertraline Versus Placebo for Major Depressive Disorder in the EMBARC Trial

EClinicalMedicine - United Kingdom
doi 10.1016/j.eclinm.2019.04.007
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Elsevier BV

Related search

Venlafaxine Versus Sertraline for Major Depressive Disorder

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2000English

Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents With Major Depressive Disorder

Journal of Child and Adolescent Psychopharmacology
Mental HealthChild HealthPharmacologyPerinatologyPsychiatryPediatrics
2018English

Third-Wave Cognitive Therapy Versus Mentalisation-Based Treatment for Major Depressive Disorder: A Randomised Clinical Trial

BMJ Open
Medicine
2014English

Pupillary Reactivity to Negative Stimuli Prospectively Predicts Recurrence of Major Depressive Disorder in Women

Psychophysiology
DevelopmentalCognitive PsychologyNeuropsychologyEducational PsychologyCognitive NeuroscienceEndocrineDevelopmental NeurosciencePhysiological PsychologyAutonomic SystemsNeurologyNeuroscienceBiological PsychiatryPhysiologyExperimental
2016English

Major Depressive Disorder

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2018English

Trial of SAGE-217 in Patients With Major Depressive Disorder

New England Journal of Medicine
Medicine
2019English

Resting-State Connectivity Predictors of Response to Psychotherapy in Major Depressive Disorder

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2015English

Major Depressive Disorder

English

Major Depressive Disorder

2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy